As a proud father of a two-year-old little girl, it's always stories the stories about children that grab my attention the most. Take for instance, a recent one that I wrote, discussing the risk of radiation-induced solid cancers in older children. The story comes from a study published in the journal JAMA Pediatrics and possible appendicitis was cited as a leading cause of abdominal/pelvic CT usage. The first question I asked myself, one that I had never asked before... was if I should be overly concerned if my daughter needs a CT scan. The good news is, one med-tech company...

A recent study published in the journal JAMA Pediatrics shows that the risk of radiation-induced solid cancers was highest for patients undergoing CT scans of the abdomen/pelvis and that abdominal/pelvic scans saw the most dramatic increase in use over the study period, especially among older children. Possible appendicitis was cited as a leading cause of abdominal/pelvic CT usage.

Two Medtronic (Minneapolis) studies, could boost the med-tech giant's diabetes control offerings in the future. The firm released results from its ASPIRE and reported that the first patients for its Overnight Closed Loop Platform study have already been enrolled. News on the studies was revealed at the American Diabetes Association (ADA; Alexandria, Virginia) 73rd Scientific Sessions.

In a move to perhaps tweak the method in which robotic laparoscopic procedures are handled, TransEnterix (Research Triangle Park, North Carolina), a private firm, has developed a robotic single-site surgical platform that is mobile and allows the surgeon to remain at the patient's side.

Wright Medical Group (Arlington, Tennessee) took a rather large leap toward solely focusing on its extremities business, after the company reported that it would sell its OrthoRecon unit.

AngioDynamics (Albany, New York) a provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, said the FDA has granted IDE approval to conduct a clinical study of the NanoKnife System for the ablation of focal prostate cancer.

Covidien (Dublin, Ireland), reported that the final results of the PUFs (Pipeline for Uncoilable or Failed Aneurysms) clinical study of its Pipeline embolization device have been published in the June issue of Radiology. Radiology is the official peer-reviewed medical journal of the Radiological Society of North America (Oak Brook, Illinois).